{
    "2020-02-03": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "outpaces",
                        "stock market gains"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "CDC Readies for Pandemic; Long Vaccine Timeline: Virus Update",
                "features": {
                    "keywords": [
                        "CDC",
                        "pandemic",
                        "vaccine timeline"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Vaxart (VXRT) to Make Vaccines to Check Coronavirus, Stock Up",
                "features": {
                    "keywords": [
                        "Vaxart",
                        "vaccines",
                        "coronavirus",
                        "stock up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "VVUS: ZenPep Deal Demonstrates PERT Interest",
                "features": {
                    "keywords": [
                        "VVUS",
                        "ZenPep",
                        "PERT interest"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AZRX: EPI Treatment in the News",
                "features": {
                    "keywords": [
                        "AZRX",
                        "EPI treatment"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Stocks - Apple Falls in Premarket; Drug Reports Lift Gilead, AbbVie",
                "features": {
                    "keywords": [
                        "Apple",
                        "falls",
                        "premarket",
                        "drug reports",
                        "Gilead",
                        "AbbVie"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}